| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net (loss) income | -54,026,555 | -24,369,193 |
| Depreciation of property and equipment | 3,682,545 | 2,432,577 |
| Amortization of intangible assets | 4,199,989 | 2,751,441 |
| Amortization of finance lease right-of-use assets | 3,831,097 | 2,558,381 |
| Loss (gain) on disposal of fixed assets | -43,668 | -33,215 |
| Deferred income tax | -22,316,655 | -8,806,213 |
| Accretion of discount related to restricted investments | 214,889 | 145,403 |
| Loss on equity method investments | -106,550 | -79,515 |
| Bad debt expense | 3,706,675 | 2,492,009 |
| Stock-based compensation | 14,306,120 | 9,656,445 |
| Loss on remeasurement of operating and finance leases | -42,367 | -47,444 |
| Finite-lived intangible asset impairment | 8,020,343 | - |
| Goodwill impairment | 8,718,398 | - |
| Loss on change in fair value of contingent consideration | 1,052,394 | 0 |
| Accounts receivable | -100,722,468 | -86,194,306 |
| Prepaid expenses and other current assets | 5,402,807 | 5,273,060 |
| Other assets | -1,026,075 | -970,612 |
| Accounts payable | -20,321,384 | -18,246,793 |
| Accrued liabilities | -2,671,275 | -7,451,661 |
| Operating lease liabilities and right-of-use assets | 413,830 | 336,596 |
| Net cash provided by operating activities | 44,918,954 | 43,260,218 |
| Purchase of property and equipment | 3,047,060 | 2,170,883 |
| Acquisition of intangibles | 2,259,569 | 1,578,173 |
| Acquisition of a business, net of cash acquired | 3,646,318 | 3,646,318 |
| Purchase of restricted investments | 24,739,136 | 22,221,437 |
| Purchase of equity method investments | 4,784 | 0 |
| Proceeds from sale and maturity of restricted investments | 7,487,919 | 2,329,246 |
| Proceeds from disposal of property and equipment | 198,167 | 177,329 |
| Net cash used in investing activities | -26,010,781 | -27,110,236 |
| Proceeds from revolving credit line | 0 | 0 |
| Repayments of revolving credit line | 30,000,000 | 0 |
| Proceeds from notes payable | 258,700 | - |
| Repayments of notes payable | 27,161 | 6,258 |
| Due to seller | 857,862 | 750,919 |
| Acquisition of noncontrolling interest | 0 | - |
| Earnout payments on contingent liabilities | 1,952,672 | 265,538 |
| Distributions paid to noncontrolling interest | 175,831 | 0 |
| Proceeds from exercise of stock options | 0 | 0 |
| Payments for taxes related to shares withheld for employee taxes | 1,403,099 | 1,340,552 |
| Common stock repurchased | 10,828,906 | 10,828,906 |
| Payments on obligations under finance lease | 3,965,618 | 2,708,673 |
| Net cash used in financing activities | -48,952,449 | -15,900,846 |
| Effect of exchange rate changes on cash and cash equivalents | 314,141 | 968,129 |
| Net (decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents | -29,730,135 | 1,217,265 |
| Cash and cash equivalents at beginning of period | 107,337,307 | - |
| Cash and cash equivalents at end of period | 77,607,172 | - |
DocGo Inc. (DCGO)
DocGo Inc. (DCGO)